Ali Tehrani

2021 - Zymeworks

In 2021, Ali Tehrani earned a total compensation of $5.1M as Former President & CEO at Zymeworks, a 5% increase compared to previous year.

Compensation breakdown

Option Awards$3,625,121
Salary$593,092
Stock Awards$870,500
Other$21,924
Total$5,110,637

Tehrani received $3.6M in option awards, accounting for 71% of the total pay in 2021.

Tehrani also received $593.1K in salary, $870.5K in stock awards and $21.9K in other compensation.

Rankings

In 2021, Ali Tehrani's compensation ranked 2,552nd out of 12,415 executives tracked by ExecPay. In other words, Tehrani earned more than 79.4% of executives.

ClassificationRankingPercentile
All
2,552
out of 12,415
79th
Division
Manufacturing
1,014
out of 5,505
82nd
Major group
Chemicals And Allied Products
390
out of 2,375
84th
Industry group
Drugs
341
out of 2,096
84th
Industry
Pharmaceutical Preparations
223
out of 1,546
86th
Source: SEC filing on November 25, 2022.

Tehrani's colleagues

We found five more compensation records of executives who worked with Ali Tehrani at Zymeworks in 2021.

2021

Neil Josephson

Zymeworks

Chief Medical Officer

2021

Anthony Polverino

Zymeworks

Chief Scientific Officer

2021

Neil Klompas

Zymeworks

Chief Financial Officer

2021

Diana Hausman

Zymeworks

Chief Medical Officer

2021

James Priour

Zymeworks

Former Chief Commercial Officer

News

In-depth

You may also like